MECHANISMS OF AFLATOXIN B₁ LUNG TUMORIGENESIS

References

• Hayes RB,Van Nieuwenhuize JP, Raatgever JW, ten Kate FJW:Afl atoxin exposures in the industrial setting:an epidemiological study of mortality. Food Chem Toxicol. 1984;22:39–43.
   Google Scholar
• Dvorackova I, Stora C, Ayraud N:Evidence for afl atoxin B1 in two cases of lung cancer in man. J Cancer Res Clin Oncol. 1981;100:221–224.
   Google Scholar
• Dvorackova I, Polster M:Relation between afl atoxin producing aspergilloma and lung carcinoma. Microbiologie Aliments Nutrition. 1984;2:187–192.
   Google Scholar
• Harrison JC, Garner RC:Immunological and HPLC detection of afl atoxin adducts in human tissues after an acute poisoning incident in S.E. Asia. Carcinogenesis. 1991;12:741–743.
   Google Scholar
• Massey TE, Stewart RK, Daniels JM, Liu L:Biochemical and molecular aspects of mammalian susceptibility to afl atoxin B1 carcinogenicity. Proc Soc Exp Biol Me d. 1995;208:213–227.
   Google Scholar
• Donnelly PJ, Devereux TR, Foley JF, Maronpot RR, Anderson MW, Massey TE:Parental allele bias in activation of K-ras in afl atoxin B1 (AFB1)-induced lung tumors of AC3F1 (A/JX C3H/HeJ) mice. Toxicologist. 1996;30:29–30.
   Google Scholar
• Essigmann JM, Croy RG, Nadzan AM, Busby WFJr, Reinhold VN, Buchi G, Wogan GN:Structural identifi cation of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci US A. 1977;74:1870–1874.
   Google Scholar
• Shen H-M, Ong C-N, Lee B-L, Shi C-Y:Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis. 1995;16:419–422.
   Google Scholar
• Daniels JM, Liu L, Stewart RK, Massey TE:Biotransformation of aflatoxin B1 in rabbit lung and liver microsomes. Carcinogenesis. 1990;11:823–827.
   Google Scholar
• Daniels JM, Massey TE:Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes. Toxicology. 1992;74:19–32.
   Google Scholar
• Daniels JM, Matula TI, Massey TE:DNA binding and mutagenicity of aflatoxin B1 catalyzed by isolated rabbit lung cells. Carcinogenesis. 1993;14:1429–1434.
   Google Scholar
• Im SH, Bolt MW, Stewart RK, Massey TE:Modulation of afl atoxin B1 biotransformation by-naphthofl avone in isolated rabbit lung cells. Arch Toxicol. 1996;71:72–79.
   Google Scholar
• Johnson WW, Guengerich FP:Reaction of aflatoxin B1 exo-8, 9-epoxide with DNA:kinetic analysis of covalent binding and DNA-induced hydrolysis. Proc Natl Acad Sci US A. 1997;94:6121–6125.
   Google Scholar
• Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER:Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 1982;126:332–337.
   Google Scholar
• Plopper CG:Comparative morphologic features of bronchiolar epithelial cells. Am Rev Respir Dis. 1983;(suppl)128:S37–S41.
   Google Scholar
• Smith MN, Greenberg SD, Spjut HJ:The Clara cell:a comparative ultrastructural study in mammals. Am J Anat. 1979;155:15–30.
   Google Scholar
• Anttila S, Hietanen E, Vainio H, Camus AM, Gelboin HV, Park SS, Heikkila L, Karjalainen A, Bartsch H:Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int J Cancer. 1991;47:681–685.
   Google Scholar
• Devereux TR, Massey TE,Van Scott MR, Yankaskas J, Fouts JR:Xenobiotic metabolism in human alveolar type II cells isolated by centrifugal elutriation and density gradient centrifugation. Cancer Res. 1986;46:5438–5443.
   Google Scholar
• Anttila S, Hukkanen J, Hakkola J, Stjernvall T, Beaune P, Edwards RJ, Boobis AR, Pelkonen O, Raunio H:Expression and localization of CYP3A4 and CYP3A5 in hu man lung. Am J Respir Cell Mol Biol. 1997;16:242–249.
   Google Scholar
• Willey JC, Coy E, Brolly C, Utell MJ, Frampton MW, Hammersley J, Thilly WG, Olson D, Cairns K:Xenobiotic metabolism enzyme gene expression in hu man bronchial and alveolar macrophage cells. Am J Respir Ce ll Mol Biol. 1996;14:262–271.
   Google Scholar
• Dvorak AM, Schleimer RP, Dvorak HF, Lichtenstein LM, Weller PF:Human lung mast cell and alveolar macrophage cytoplasmic lipid bodies contain arachidonic acid and prostaglandin endoperoxide synthase (cyclooxygenase), the substrate and enzyme necessary for prostaglandin production. Int Arch Allergy Immunol. 1992;99:208–217.
   Google Scholar
• Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, Serhan CN:Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5, 8, 11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest. 1993;92:1572–1579.
   Google Scholar
• Donnelly PJ, Stewart RK, Ali SL, Conlan AA, Reid KR, Petsikas D, Massey TE:Biotransformation of aflatoxin B1 in human lung. Carcinogenesis. 1996;17:2487–2494.
   Google Scholar
• Liu L, Massey TE:Bioactivation of aflatoxin B1 by lipoxygenases, prostaglandin H synthase and cytochrome P450 monooxygenase in guinea-pig tissues. Carcinogenesis. 1992;13:533–539.
   Google Scholar
• Stewart RK, Serabjit-Singh CJ, Massey TE:Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in rabbit lung and liver. Toxicol Appl Pharmacol. 1996;140:499–507.
   Google Scholar
• Board PG:Biochemical genetics of glutathione-S-transferase in man. Am J Human Genet. 1981;33:36–43.
   Google Scholar
• Raney KD, Meyer DJ, Ketterer B, Harris TM, Guengerich FP:Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases. Chem Res Toxicol. 1992;5:470–478.
   Google Scholar
• Johnson WW, Ueng YF, Widersten M, Mannervik B, Hayes JD, Sherratt PJ, Ketterer B, Guengerich FP:Conjugation of highly reactive afl atoxin B1 exo-8, 9-epoxide catalyzed by rat and human glutathione transferases:estimation of kinetic parameters. Biochemistry. 1997;36:3056–3060.
   Google Scholar
• Stewart RK, Smith GBJ, Donnelly PJ, Reid KR, Petsikas D, Conlan AA, Massey TE:Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in hu man lung:differential cellular distribution and lack of signifi cance of the GSTM1 genetic polymorphism. Carcinogenesis. 1999;20:1971–1977.
   Google Scholar
• Rodenhuis S, Slebos RJC:The ras oncogenes in human lung cancer. Am Rev Respir Dis. 1990;(suppl)142:S27–S30.
   Google Scholar
• Anderson MW, Reynolds SH, You M, Maronpot RR:Role of proto-oncogene activation in carcinogenesis. Environ Health Pe rspect. 1992;98:13–24.
   Google Scholar
• Anderson MW:Oncogenes, growth factors, and cell signaling in mouse lung tumors:An overview. Exp Lung Res. 1991;17:323–325.
   Google Scholar
• Donnelly PJ, Devereux TR, Foley JF, Maronpot RR, Anderson MW, Massey TE:Activation of K-ras in aflatoxin B1-induced lung tumors from AC3F1(A/J x C3H/HeJ) mice. Carcinogenesis. 1996;17:1735–1740.
   Google Scholar
• Malkinson AM:The genetic basis of susceptibility to lung tu mors in mice. Toxicology. 1989;54:241–271.
   Google Scholar
• Malkinson AM, Nesbitt MN, Skamene E:Susceptibility to urethan-induced pulmonary adenomas between A/J and C57BL/6J mice:use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model. J Natl Cancer Inst. 1985;75:971–974.
   Google Scholar
• Jacobson DR, Mills NE:A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene. 1994;9:553–563.
   Google Scholar
• Donnelly PJ, Massey TE:Ki-ras activation in lung cells isolated from AC3F1 (A/JC3H/HeJ) mice after treatment with aflatoxin B1. Mol Carcinog. 1999;26:62–67.
   Google Scholar
• Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P:Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989;342:705–708.
   Google Scholar
• Weinberg RA:Tumor suppressor genes. Science. 1991;254:1138–1146.
   Google Scholar
• Hollstein M, Sidransky D, Vogelstein B, Harris CC:p53 mutations in human cancers. Science. 1991;253:49–53.
   Google Scholar
• Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW:Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991;51:6304–6311.
   Google Scholar
• Soini Y, Chia SC, Bennett WP, Groopman JD, Wang JS, DeBenedetti VM, Cawley H, Welsh JA, Hansen C, Bergasa NV, Jones EA, DiBisceglie AM, Trivers GE, Sandoval CA, Calderon IE, Munoz EL, Harris CC:An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Me xico. Carcinogenesis. 1996;17:1007–1012.
   Google Scholar
• Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P:Geographic variation of p53 mutational profi le in non malignant hu man liver. Science. 1994;264:1317–1319.
   Google Scholar
• Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC:Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991;350:427–428.
   Google Scholar
• Bressac B, Kew M, Wands J, Ozturk M:Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature. 1991;350:429–431.
   Google Scholar
• Ozturk M:p53 Mutation in hepatocellular carcinoma after afl atoxin exposure. Lancet. 1991;338:1356–1359.
   Google Scholar
• Scorsone KA, Zhou Y-Z, Butel JS, Slagle BL:p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res. 1992;52:1635–1638.
   Google Scholar
• Dragani TA, Manenti G, Pierotti MA:Genetics of murine lung tumors. Adv Cancer Res. 1995;67:83–112.
   Google Scholar
• Goodrow TL, Storer RD, Leander KR, Prahalada SR,van Zwieten MJ, Bradley MO:Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors. Mol Carcinog. 1992;5:9–15.
   Google Scholar
• Chen B, Liu L, Castonguay A, Maronpot RR, Anderson MW, You M:Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mou se lung tumors. Carcinogenesis. 1993;14:1603–1608.
   Google Scholar
• Devereux TR, Belinsky SA, Maronpot RR, White CM, Hegi ME, Patel AC, Foley JF, Greenwell A, Anderson MW:Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mou se strains. Mol Carcinog. 1993;8:177–185.
   Google Scholar
• Li EE, Heflich RH, Bucci TJ, Manjanatha MG, Blaydes BS, Delclos KB:Relationships of DNA adduct formation, K-ras activating mutations and tumorigenic activities of 6-nitrochrysene and its metabolites in the lungs of CD-1 mice. Carcinogenesis. 1994;15:1377–1385.
   Google Scholar
• Hegi ME, Soderkvist P, Foley JF, Schoonhoven R, Swenberg JA, Kari F, Maronpot RR, Anderson MW, Wiseman RW:Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis. 1993;14:803–810.
   Google Scholar
• Horio Y, Chen A, Rice P, Roth JA, Malkinson AM, Schrump DS:Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol Carcinog. 1996;17:217–223.
   Google Scholar
• Tam AS, Foley JF, Devereux TR, Maronpot RR, Massey TE:High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mou se lung tumors. Cancer Res. 1999;59:3634–3640.
   Google Scholar
• Miller MS:Tumor suppressor genes in rodent lung carcinogenesis-mutation of p53 does not appear to be an early lesion in lung tumor pathogenesis. Toxicol Appl Pharmacol. 1999;156:70–77.
   Google Scholar
• Zhang Y, Xiong Y, Yarbrough WG:ARF promotes MDM2 degradation and stabilizes p53:ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 1998;92:725–734.
   Google Scholar
• Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA:The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Ce ll. 1998;92:713–723.
   Google Scholar
• Haupt Y, Maya R, Kazaz A, Oren M:Md m2 promotes the rapid degradation of p53. Nature. 1997;387:296–299.
   Google Scholar
• Ginsberg GL, Atherholt TB:Transport of DNA-adducting metabolites in mouse serum following benzo[a]pyrene administration. Carcinogenesis. 1989;10:673–679.
   Google Scholar
• Umbenhauer DR, Pegg AE:Alkylation of intracellular and extracellular DNA by dimethylnitrosamine following activation by isolated rat hepatocytes. Cancer Res. 1981;41:3471–3474.
   Google Scholar
• Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW, Wiseman RW:Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res. 1994;54:6257–6264.
   Google Scholar
• Herzog CR, Wiseman RW, You M:Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res. 1994;54:4007–4010.
   Google Scholar
• Belinsky SA, Swafford DS, Middleton SK, Kennedy CH, Tesfaigzi J:Deletion and differential expression of p16INK4a in mouse lung tu mors. Carcinogenesis. 1997;18:115–120.
   Google Scholar
• Gressani KM, Rollins LA, Leone-Kabler S, Cline JM, Miller MS:Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in ute ro to 3-methylcholanthrene. Carcinogenesis. 1998;19:1045–1052.
   Google Scholar